FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3213225 · Received July 9, 2013

Report

Report Number
2124215-2013-09832
Event Type
Injury
Date Received
July 9, 2013
Date of Event
February 7, 2013
Report Date
June 7, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT'S RIGHT VENTRICULAR (RV) LEAD WAS EXHIBITING HIGH (OUT OF RANGE) PACING AND SHOCKING IMPEDANCE MEASUREMENTS. A REVISION PROCEDURE WAS PERFORMED TO CHECK THIS SYSTEM, WHEN THE POCKET WAS OPENED, THE PHYSICIAN NOTED THE PATIENT WAS DEVELOPING AN INFECTION. THEREFORE, THE ENTIRE SYSTEM WAS EXPLANTD AND THE PATIENT IS BEING TREATED WITH ANTIBIOTICS. A NEW SYSTEM WILL BE IMPLANTED WHEN THE INFECTION IS GONE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
311977 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 59 YR Hospitalization| L| R 5076| E110| 0158